Assessing the value of biopharmaceutical innovation in key therapy areas in middle-income countries
Related news and resources
Renewed partnership to boost the skills needed to drive drug discovery and development in Africa
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and H3D Foundation have today announced a new three-year phase of their partnership, aiming to boost the skills and capacity needed to drive increased research and development of new medicines in Africa.
Read more
IFPMA Statement at the WIPO Standing Committee on the Law of Patents (SCP) 35
On 17 October in Geneva, IFPMA submitted a statement at the WIPO Standing Committee on the Law of Patents (SCP) 35.
Read moreInnovative pharmaceutical industry statement on draft WHO Pandemic Treaty: We need to preserve what went well and address what went wrong
On 16 October 2023, IFPMA issued a statement in response to draft WHO Pandemic Treaty.
Read more